These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 10321757)

  • 41. The use of antineutrophil cytoplasmic antibodies to determine clinical patterns of ulcerative colitis in children.
    Ferry GD
    J Pediatr Gastroenterol Nutr; 1998 Apr; 26(4):475-7. PubMed ID: 9552150
    [No Abstract]   [Full Text] [Related]  

  • 42. [p-ANCA prevalence in ulcerative colitis patients and first-degree relatives].
    Toader E; Durnea C
    Rev Med Chir Soc Med Nat Iasi; 2010; 114(3):687-93. PubMed ID: 21243793
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The role of cytokine gene polymorphisms in determining disease susceptibility and phenotype in inflammatory bowel disease.
    Cantor MJ; Nickerson P; Bernstein CN
    Am J Gastroenterol; 2005 May; 100(5):1134-42. PubMed ID: 15842590
    [TBL] [Abstract][Full Text] [Related]  

  • 44. ANCA in IBD: nice, but necessary?
    Heiman DR; DiPalma JA
    Am J Gastroenterol; 1995 Nov; 90(11):2066-7. PubMed ID: 7485033
    [No Abstract]   [Full Text] [Related]  

  • 45. Anti-neutrophil cytoplasmic antibodies in Brazilian patients with inflammatory bowel disease.
    Cabral VL; Miszputen SJ; Catapani WR
    Hepatogastroenterology; 2003; 50(50):412-5. PubMed ID: 12749235
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antineutrophil cytoplasmic antibodies in relatives of patients with inflammatory bowel disease.
    Papo M; Quer JC; Pastor RM; García-Pardo G; Prats E; Mirapeix E; Rodríguez R; Richart C
    Am J Gastroenterol; 1996 Aug; 91(8):1512-5. PubMed ID: 8759652
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antineutrophil antibodies in familial inflammatory bowel disease.
    Lee JC; Lennard-Jones JE; Cambridge G
    Gastroenterology; 1995 Feb; 108(2):428-33. PubMed ID: 7835584
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Five genetic markers in the interleukin 1 family in relation to inflammatory bowel disease.
    Stokkers PC; van Aken BE; Basoski N; Reitsma PH; Tytgat GN; van Deventer SJ
    Gut; 1998 Jul; 43(1):33-9. PubMed ID: 9771403
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Neutrophil autoantibodies: a genetic marker in primary sclerosing cholangitis and ulcerative colitis.
    Seibold F; Slametschka D; Gregor M; Weber P
    Gastroenterology; 1994 Aug; 107(2):532-6. PubMed ID: 8039629
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Evidence of genetic heterogeneity in IBD: 1. The interleukin-1 receptor antagonist in the predisposition to suffer from ulcerative colitis.
    Bioque G; Bouma G; Crusius JB; Koutroubakis I; Kostense PJ; Meuwissen SG; Peña AS
    Eur J Gastroenterol Hepatol; 1996 Feb; 8(2):105-10. PubMed ID: 8723412
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The contribution of HLA genes to IBD susceptibility and phenotype.
    Yap LM; Ahmad T; Jewell DP
    Best Pract Res Clin Gastroenterol; 2004 Jun; 18(3):577-96. PubMed ID: 15157829
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Genetics of inflammatory bowel disease--an update.
    van Heel DA; Jewell DP
    Acta Gastroenterol Belg; 2001; 64(2):160-4. PubMed ID: 11475126
    [No Abstract]   [Full Text] [Related]  

  • 53. P-ANCA for ulcerative colitis management-hype or hope?
    Koch TR
    Am J Gastroenterol; 2002 Feb; 97(2):485. PubMed ID: 11866293
    [No Abstract]   [Full Text] [Related]  

  • 54. Genetic markers linked to rheumatoid arthritis are also strongly associated with articular manifestations in ulcerative colitis patients.
    Núñez C; Alecsandru DM; Mendoza JL; Urcelay E; Díaz-Rubio M; de la Concha EG; Martinez A
    Hum Immunol; 2006; 67(4-5):324-30. PubMed ID: 16720213
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Tumor necrosis factor polymorphism in sarcoidosis.
    Sharma OP
    Chest; 2001 Mar; 119(3):678-9. PubMed ID: 11243939
    [No Abstract]   [Full Text] [Related]  

  • 56. [Ulcerative colitis and Crohn's disease].
    Matsuoka K; Hibi T
    Nihon Rinsho; 2005 May; 63 Suppl 5():507-11. PubMed ID: 15954400
    [No Abstract]   [Full Text] [Related]  

  • 57. Lack of current clinical value of serological testing in the evaluation of patients with IBD.
    MacDermott RP
    Inflamm Bowel Dis; 1999 Feb; 5(1):64-5; discussion 66-7. PubMed ID: 10028451
    [No Abstract]   [Full Text] [Related]  

  • 58. Polymorphisms in the promoter region of tumor necrosis factor alpha (TNF-alpha) and the HLA-DRB1 locus in Mexican mestizo patients with ulcerative colitis.
    Yamamoto-Furusho JK; Uscanga LF; Vargas-Alarcón G; Rodríguez-Pérez JM; Zuñiga J; Granados J
    Immunol Lett; 2004 Aug; 95(1):31-5. PubMed ID: 15325795
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Ulcerative colitis. Clinical diagnosis].
    Knebel U; Brambs HJ; Riemann JF
    Z Gastroenterol; 2004 Sep; 42(9):987-92. PubMed ID: 15455269
    [No Abstract]   [Full Text] [Related]  

  • 60. Polymorphism in the microsatellite located in the promoters of the Tnfa and Tnfb genes of different mouse strains.
    Iraqi F; Teale A
    Immunogenetics; 1998 Sep; 48(4):302-4. PubMed ID: 9716651
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.